{domain:"www.qualitydigest.com",server:"169.47.211.87"} Skip to main content

User account menu
Main navigation
  • Topics
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Videos/Webinars
    • All videos
    • Product Demos
    • Webinars
  • Advertise
    • Advertise
    • Submit B2B Press Release
    • Write for us
  • Metrology Hub
  • Training
  • Subscribe
  • Log in
Mobile Menu
  • Home
  • Topics
    • 3D Metrology-CMSC
    • Customer Care
    • FDA Compliance
    • Healthcare
    • Innovation
    • Lean
    • Management
    • Metrology
    • Operations
    • Risk Management
    • Six Sigma
    • Standards
    • Statistics
    • Supply Chain
    • Sustainability
    • Training
  • Login / Subscribe
  • More...
    • All Features
    • All News
    • All Videos
    • Contact
    • Training

The Rise and Fall of Theranos

So many lessons in a drop of blood

Norman A. Paradis
Wed, 05/04/2016 - 15:16
  • Comment
  • RSS

Social Sharing block

  • Print
  • Add new comment
Body

The last few months have witnessed the unraveling of the remarkable life sciences company Theranos, culminating in the news that federal regulators may ban Theranos founder Elizabeth Holmes from the blood-testing industry for at least two years. The company is also facing a federal criminal investigation into whether its investors were misled about its technology and company operations.

ADVERTISEMENT

How has this widely acclaimed biomedical innovator fallen so far, so fast?

Theranos’ revolutionary claim that won over investors was that it could accurately run tests using a small amount of blood taken from a poke in the patient’s finger, instead of a syringe full from a needle stuck in a vein. The idea was that dozens of tests, such as cholesterol and thyroid hormone levels, could be run on a single, tiny blood sample.

 …

Want to continue?
Log in or create a FREE account.
Enter your username or email address
Enter the password that accompanies your username.
By logging in you agree to receive communication from Quality Digest. Privacy Policy.
Create a FREE account
Forgot My Password

Comments

Submitted by George Rodrigues on Wed, 05/04/2016 - 10:03

Board of Directors Mentioned by Buffett

The board was given as an example of what not to do, during the Berkshire Hathaway annual meeting last week.

https://www.theranos.com/leadership

Hindsight is 20/20, but in retrospect it's pretty clear that the Board was selected for Big Names with Big Influence.  It hard to imagine Sam Nunn and Henry Kissinger selected for their expertise in Business, or Medicine.

  • Reply

Submitted by George Rodrigues on Wed, 05/04/2016 - 10:04

Board of Directors Mentioned by Buffett

The board was given as an example of what not to do, during the Berkshire Hathaway annual meeting last week.

https://www.theranos.com/leadership

Hindsight is 20/20, but in retrospect it's pretty clear that the Board was selected for Big Names with Big Influence.  It hard to imagine Sam Nunn and Henry Kissinger selected for their expertise in Business, or Medicine.

  • Reply

Add new comment

Image CAPTCHA
Enter the characters shown in the image.
Please login to comment.
      

© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.

footer
  • Home
  • Print QD: 1995-2008
  • Print QD: 2008-2009
  • Videos
  • Privacy Policy
  • Write for us
footer second menu
  • Subscribe to Quality Digest
  • About Us
  • Contact Us